resTORbio Company

resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.The Company develops medicines and therapies to treat aging-related diseases and conditions such as cancer, heart disease, neurodegenerative diseases, and diabetes mellitus. resTORbio serves clients in the State of Massachusetts.
Technology: Geroscience
Industry: Neurological disorders
Headquarters: United States
Founded Date: 2016-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 2
Total Funding: $65M
Estimated Revenue: $1M to $10M
Last Funding Type: Seed

Visit Website
Register and Claim Ownership